Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib adjunctive treatment for major depressive disorder
IRCT138711141556N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of celecoxib in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Apr 2007; status: completed.
02
Drugs
celecoxib
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT138711141556N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138711141556N5.